Illumina
NasdaqGS:ILMN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 94 Fair Values set on narratives written by author
WA
Consensus Narrative from 25 Analysts
Customer Collaboration And NovaSeq X Transition Will Drive Future Profitability And Sequencing Adoption
Key Takeaways Enhanced customer collaboration and continuous innovation drive product adoption, boosting revenue and aligning developments with customer needs for advanced sequencing. Operational excellence, capital allocation, and NovaSeq X transition aim to improve profitability, offset pricing pressure, and drive shareholder value.
View narrativeUS$162.13
FV
41.9% undervalued intrinsic discount3.97%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
24 days ago author updated this narrative